Consultant-led education CPD accredited

Current pitfalls in HSCT: Managing anicteric VOD and the impact of COVID-19 on local practice

In this webinar, Prof. Antonio Pagliuca starts by discussing the impact of COVID-19 on clinical practice at King’s College Hospital. Prof. Selim Corbacioglu then talks about the importance of recognising anicteric VOD in adults and children alike. Finally, Prof. Pagliuca presents a case study of a patient with anicteric VOD.

Topics:

Case studies Diagnosis and severity grading Risk assessment and monitoring Treatment

ADVERSE EVENTS REPORTING

Adverse events should be reported. Reporting forms and information for the UK can be found at: https://yellowcard.mhra.gov.uk/

For Ireland, reporting forms and information can be found at: www.hpra.ie

Adverse events should also be reported to Jazz Pharmaceuticals at: AEreporting@jazzpharma.com

Defitelio® is indicated for the treatment of severe hepatic veno-occlusive disease (VOD) also known as sinusoidal obstruction syndrome (SOS) in haematopoietic stem-cell transplantation (HSCT) therapy. It is indicated in adults and in adolescents, children and infants over 1 month of age.